Cargando…

Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?

INTRODUCTION: Pyloroplasty and gastric peroral endoscopic myotomy (G-POEM) are effective surgeries for gastroparesis. The primary aim of this study was to evaluate outcomes of pyloroplasty and G-POEM in patients with gastroparesis and determine factors associated with favorable outcome. The secondar...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Sven E., Zheng, Ping, Morton, Scott, Maurer, Nicole, Hoppo, Toshitaka, Jobe, Blair A., Ayazi, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234860/
https://www.ncbi.nlm.nih.gov/pubmed/36749378
http://dx.doi.org/10.1007/s00464-023-09882-2
_version_ 1785052594172854272
author Eriksson, Sven E.
Zheng, Ping
Morton, Scott
Maurer, Nicole
Hoppo, Toshitaka
Jobe, Blair A.
Ayazi, Shahin
author_facet Eriksson, Sven E.
Zheng, Ping
Morton, Scott
Maurer, Nicole
Hoppo, Toshitaka
Jobe, Blair A.
Ayazi, Shahin
author_sort Eriksson, Sven E.
collection PubMed
description INTRODUCTION: Pyloroplasty and gastric peroral endoscopic myotomy (G-POEM) are effective surgeries for gastroparesis. The primary aim of this study was to evaluate outcomes of pyloroplasty and G-POEM in patients with gastroparesis and determine factors associated with favorable outcome. The secondary aim was to assess the utility of clinical response to preoperative pyloric dilation or botulinum toxin injection (Botox) on surgical outcome, a factor conventionally used as a favorable marker. METHODS: There were 204 patients who underwent pyloroplasty (n = 177) or G-POEM (n = 27) for gastroparesis at our institution from 2014 to 2021. Demographic and clinical parameters were analyzed to assess their impact on surgical outcome. A subgroup of patients who had pyloric dilation or Botox injection were assessed separately. Favorable outcome was defined as patient reported complete resolution of the predominant gastroparesis symptom. RESULTS: Favorable outcome was achieved in 78.4% of patients (pyloroplasty: 79.7% and G-POEM: 70.4%, p = 0.274). Among 61 patients where pre- and postoperative gastric emptying studies (GES) were available, mean 4-hour retention significantly improved from 33.5 to 15.0% (p < 0.001) and 77.0% of patients achieved normalization. Favorable outcome was not significantly impacted by etiology of gastroparesis (p = 0.120), GERD (p = 0.518), or primary gastroparesis symptom (p = 0.244). Age ≥ 40 was a significant predictor of favorable surgical outcome on multivariate analysis [OR: 2.476 (1.224–5.008), p = 0.012]. Among the patients who had preoperative dilation (n = 82) or Botox injection (n = 46), response to these interventions was not a predictor of favorable surgical outcome (p = 0.192 and 0.979, respectively). However, preoperative Botox injection, regardless of response to injection, was associated with favorable surgical outcome [OR: 3.205 (CI 1.105–9.299), p = 0.032]. CONCLUSION: Symptomatic improvement after pyloroplasty or G-POEM is independent of etiology of gastroparesis, GERD, and primary symptom. Response to dilation or Botox are not markers of response to surgery. However, patients who receive Botox are 3.2 times more likely to improve postoperatively. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10234860
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-102348602023-06-03 Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome? Eriksson, Sven E. Zheng, Ping Morton, Scott Maurer, Nicole Hoppo, Toshitaka Jobe, Blair A. Ayazi, Shahin Surg Endosc Original Article INTRODUCTION: Pyloroplasty and gastric peroral endoscopic myotomy (G-POEM) are effective surgeries for gastroparesis. The primary aim of this study was to evaluate outcomes of pyloroplasty and G-POEM in patients with gastroparesis and determine factors associated with favorable outcome. The secondary aim was to assess the utility of clinical response to preoperative pyloric dilation or botulinum toxin injection (Botox) on surgical outcome, a factor conventionally used as a favorable marker. METHODS: There were 204 patients who underwent pyloroplasty (n = 177) or G-POEM (n = 27) for gastroparesis at our institution from 2014 to 2021. Demographic and clinical parameters were analyzed to assess their impact on surgical outcome. A subgroup of patients who had pyloric dilation or Botox injection were assessed separately. Favorable outcome was defined as patient reported complete resolution of the predominant gastroparesis symptom. RESULTS: Favorable outcome was achieved in 78.4% of patients (pyloroplasty: 79.7% and G-POEM: 70.4%, p = 0.274). Among 61 patients where pre- and postoperative gastric emptying studies (GES) were available, mean 4-hour retention significantly improved from 33.5 to 15.0% (p < 0.001) and 77.0% of patients achieved normalization. Favorable outcome was not significantly impacted by etiology of gastroparesis (p = 0.120), GERD (p = 0.518), or primary gastroparesis symptom (p = 0.244). Age ≥ 40 was a significant predictor of favorable surgical outcome on multivariate analysis [OR: 2.476 (1.224–5.008), p = 0.012]. Among the patients who had preoperative dilation (n = 82) or Botox injection (n = 46), response to these interventions was not a predictor of favorable surgical outcome (p = 0.192 and 0.979, respectively). However, preoperative Botox injection, regardless of response to injection, was associated with favorable surgical outcome [OR: 3.205 (CI 1.105–9.299), p = 0.032]. CONCLUSION: Symptomatic improvement after pyloroplasty or G-POEM is independent of etiology of gastroparesis, GERD, and primary symptom. Response to dilation or Botox are not markers of response to surgery. However, patients who receive Botox are 3.2 times more likely to improve postoperatively. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-02-07 2023 /pmc/articles/PMC10234860/ /pubmed/36749378 http://dx.doi.org/10.1007/s00464-023-09882-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Eriksson, Sven E.
Zheng, Ping
Morton, Scott
Maurer, Nicole
Hoppo, Toshitaka
Jobe, Blair A.
Ayazi, Shahin
Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
title Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
title_full Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
title_fullStr Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
title_full_unstemmed Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
title_short Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome?
title_sort predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or botox injection be used as a marker of surgical outcome?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234860/
https://www.ncbi.nlm.nih.gov/pubmed/36749378
http://dx.doi.org/10.1007/s00464-023-09882-2
work_keys_str_mv AT erikssonsvene predictorsoffavorableoutcomeafterpyloroplastyforgastroparesisshouldresponsetopyloricdilationorbotoxinjectionbeusedasamarkerofsurgicaloutcome
AT zhengping predictorsoffavorableoutcomeafterpyloroplastyforgastroparesisshouldresponsetopyloricdilationorbotoxinjectionbeusedasamarkerofsurgicaloutcome
AT mortonscott predictorsoffavorableoutcomeafterpyloroplastyforgastroparesisshouldresponsetopyloricdilationorbotoxinjectionbeusedasamarkerofsurgicaloutcome
AT maurernicole predictorsoffavorableoutcomeafterpyloroplastyforgastroparesisshouldresponsetopyloricdilationorbotoxinjectionbeusedasamarkerofsurgicaloutcome
AT hoppotoshitaka predictorsoffavorableoutcomeafterpyloroplastyforgastroparesisshouldresponsetopyloricdilationorbotoxinjectionbeusedasamarkerofsurgicaloutcome
AT jobeblaira predictorsoffavorableoutcomeafterpyloroplastyforgastroparesisshouldresponsetopyloricdilationorbotoxinjectionbeusedasamarkerofsurgicaloutcome
AT ayazishahin predictorsoffavorableoutcomeafterpyloroplastyforgastroparesisshouldresponsetopyloricdilationorbotoxinjectionbeusedasamarkerofsurgicaloutcome